|
maturation of ssu rrna
|
GO:0030490 |
1 |
0.346
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.253
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.187
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.177
|
|
|
ribosomal small subunit biogenesis
|
GO:0042274 |
4 |
0.175
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.159
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.148
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.132
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.126
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.122
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.121
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.109
|
|
|
translational initiation
|
GO:0006413 |
24 |
0.104
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.098
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.097
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.094
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.091
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.091
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.091
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.090
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.086
|
|
|
ribosome biogenesis
|
GO:0042254 |
20 |
0.084
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.077
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.071
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.068
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.066
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.062
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.062
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.061
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.060
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.060
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.060
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.059
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.059
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.058
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.058
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.057
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.056
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.055
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.052
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.051
|
|
|
protein import
|
GO:0017038 |
101 |
0.050
|
|
|
kidney development
|
GO:0001822 |
213 |
0.050
|
|
|
endonucleolytic cleavage involved in rrna processing
|
GO:0000478 |
1 |
0.049
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.047
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.047
|
|
|
intracellular sterol transport
|
GO:0032366 |
3 |
0.047
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.044
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.044
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.043
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.042
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.041
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.041
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.040
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.039
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.039
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.039
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.038
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.036
|
|
|
endonucleolytic cleavage of tricistronic rrna transcript ssu rrna 5 8s rrna lsu rrna
|
GO:0000479 |
1 |
0.036
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.036
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.036
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.036
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.035
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.034
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.034
|
|
|
regulation of cyclase activity
|
GO:0031279 |
13 |
0.034
|
|
|
translation
|
GO:0006412 |
93 |
0.033
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.033
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.033
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.033
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.033
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.032
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.032
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.031
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.031
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.031
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.031
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.031
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.031
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.030
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.030
|
|
|
negative regulation of tyrosine phosphorylation of stat3 protein
|
GO:0042518 |
1 |
0.030
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.030
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.030
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.030
|
|
|
cleavage involved in rrna processing
|
GO:0000469 |
1 |
0.029
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.029
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.029
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.028
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.028
|
|
|
action potential
|
GO:0001508 |
78 |
0.028
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.028
|
|
|
positive regulation of rac protein signal transduction
|
GO:0035022 |
1 |
0.028
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.028
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.027
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.027
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.027
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.027
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.027
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.027
|
|
|
cellular response to interleukin 15
|
GO:0071350 |
2 |
0.026
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.026
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.026
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.026
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.026
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.026
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.026
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.026
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.025
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
26 |
0.025
|
|
|
regulation of exit from mitosis
|
GO:0007096 |
1 |
0.025
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.025
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.025
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.024
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.024
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.024
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.024
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.023
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
26 |
0.023
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.023
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.023
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.023
|
|
|
polyamine transport
|
GO:0015846 |
5 |
0.023
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.023
|
|
|
neuron death
|
GO:0070997 |
154 |
0.023
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.023
|
|
|
maturation of 5 8s rrna from tricistronic rrna transcript ssu rrna 5 8s rrna lsu rrna
|
GO:0000466 |
1 |
0.023
|
|
|
tumor necrosis factor mediated signaling pathway
|
GO:0033209 |
13 |
0.022
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.022
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
36 |
0.022
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.022
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.022
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.022
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.022
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.022
|
|
|
rna processing
|
GO:0006396 |
105 |
0.021
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.021
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.021
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.021
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.021
|
|
|
organism emergence from protective structure
|
GO:0071684 |
4 |
0.021
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.021
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.021
|
|
|
negative regulation of myeloid leukocyte differentiation
|
GO:0002762 |
20 |
0.021
|
|
|
negative regulation of pathway restricted smad protein phosphorylation
|
GO:0060394 |
1 |
0.020
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.020
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.020
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.020
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.020
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.020
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.020
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.019
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.019
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.019
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.019
|
|
|
negative regulation of tyrosine phosphorylation of stat protein
|
GO:0042532 |
3 |
0.019
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.019
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.019
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.019
|
|
|
ribonucleoprotein complex disassembly
|
GO:0032988 |
3 |
0.019
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.019
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.019
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
44 |
0.019
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.019
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.019
|
|
|
pyrimidine nucleoside metabolic process
|
GO:0006213 |
2 |
0.019
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.018
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.018
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.018
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.018
|
|
|
ossification
|
GO:0001503 |
216 |
0.018
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
20 |
0.018
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.018
|
|
|
regulation of transcription from rna polymerase i promoter
|
GO:0006356 |
6 |
0.018
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.018
|
|
|
methylation
|
GO:0032259 |
134 |
0.018
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.017
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.017
|
|
|
adenylate cyclase activating g protein coupled receptor signaling pathway
|
GO:0007189 |
30 |
0.017
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.017
|
|
|
lung development
|
GO:0030324 |
164 |
0.017
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.017
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.016
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.016
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.016
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.016
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.016
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.016
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.016
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.016
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.016
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.016
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.016
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.016
|
|
|
maturation of ssu rrna from tricistronic rrna transcript ssu rrna 5 8s rrna lsu rrna
|
GO:0000462 |
1 |
0.016
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.016
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.016
|
|
|
regulation of systemic arterial blood pressure by norepinephrine epinephrine
|
GO:0001993 |
8 |
0.015
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.015
|
|
|
cell division
|
GO:0051301 |
120 |
0.015
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.015
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.015
|
|
|
regionalization
|
GO:0003002 |
337 |
0.015
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.015
|
|
|
coagulation
|
GO:0050817 |
78 |
0.015
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.015
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.015
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.015
|
|
|
ribonucleoprotein complex localization
|
GO:0071166 |
1 |
0.015
|
|
|
hatching
|
GO:0035188 |
4 |
0.014
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.014
|
|
|
toxin transport
|
GO:1901998 |
38 |
0.014
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.014
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
26 |
0.014
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.014
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.014
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.014
|
|
|
intracellular lipid transport
|
GO:0032365 |
3 |
0.014
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.014
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.014
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.014
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
30 |
0.014
|
|
|
rrna processing
|
GO:0006364 |
10 |
0.014
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.014
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.014
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.014
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.013
|
|
|
positive regulation of cellular respiration
|
GO:1901857 |
3 |
0.013
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.013
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.013
|
|
|
tyrosine phosphorylation of stat1 protein
|
GO:0042508 |
3 |
0.013
|
|
|
cell growth
|
GO:0016049 |
130 |
0.013
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.013
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.013
|
|
|
rna 5 end processing
|
GO:0000966 |
1 |
0.013
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.013
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.013
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.013
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.013
|
|
|
peripheral nervous system neuron axonogenesis
|
GO:0048936 |
3 |
0.013
|
|
|
polyamine biosynthetic process
|
GO:0006596 |
2 |
0.013
|
|
|
organelle disassembly
|
GO:1903008 |
2 |
0.013
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.013
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.013
|
|
|
regulation of platelet derived growth factor receptor beta signaling pathway
|
GO:2000586 |
2 |
0.013
|
|
|
gland development
|
GO:0048732 |
330 |
0.012
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.012
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.012
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.012
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.012
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.012
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.012
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.012
|
|
|
negative regulation of binding
|
GO:0051100 |
39 |
0.012
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.012
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.012
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.012
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.012
|
|
|
positive regulation of camp metabolic process
|
GO:0030816 |
19 |
0.012
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.012
|
|
|
negative regulation of vascular endothelial growth factor receptor signaling pathway
|
GO:0030948 |
6 |
0.012
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.012
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.012
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.012
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.012
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.012
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.011
|
|
|
rap protein signal transduction
|
GO:0032486 |
3 |
0.011
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.011
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.011
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.011
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.011
|
|
|
negative regulation of platelet derived growth factor receptor beta signaling pathway
|
GO:2000587 |
2 |
0.011
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.011
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.011
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.011
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.011
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.011
|
|
|
positive regulation of transcription by galactose
|
GO:0000411 |
1 |
0.011
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.011
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.011
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.011
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.011
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.011
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.011
|
|
|
renal system development
|
GO:0072001 |
225 |
0.011
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
55 |
0.011
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.011
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.011
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.011
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.011
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.011
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.010
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.010
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.010
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.010
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.010
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.010
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.010
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.010
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.010
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.010
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.010
|
|